The board of directors of Karo Pharma Aktiebolag (”Karo Pharma”) has resolved to postpone the publication of the interim report for the period January – September 2019 to 15 November 2019. The previously announced date for publication was 1 November 2019. The delay is due to the ongoing integration process relating to Karo Pharma’s acquisition of Trimb, which was completed on 12 September 2019.
For additional information, please contact:
Christoffer Lorenzen, CEO, +4673-501 76 20, firstname.lastname@example.org
Jon Johnsson, CFO, +4673-507 88 61, email@example.com